Table 1 Demographic and clinical characteristics at treatment initiation
Total | ||
|---|---|---|
(n = 736) | ||
n | % | |
Gender | ||
Male | 470 | 63.9% |
Female | 265 | 36.1% |
Age (years) | ||
Mean (±SD) | 10.0 ± 3.14 | |
5-11 (children) | 497 | 67.5% |
12-17 (adolescents) | 239 | 32.5% |
Patients with polysensitisation* | 375 | 62.3% |
Pathology of respiratory allergy | ||
Rhinitis alone | 265 | 36.0% |
Rhinitis + asthma | 438 | 59.5% |
Asthma alone | 33 | 4.5% |
Allergic rhinitis (with or without asthma) | ||
Disease duration (years) | ||
n | 703 | 95.5% |
Mean (±SD) | 3.57 ± 2.43 | |
Severity (ARIA)** | ||
Mild intermittent | 57 | 8.1% |
Moderate or severe intermittent | 56 | 8.0% |
Mild persistent | 148 | 21.1% |
Moderate or severe persistent | 440 | 62.8% |
Allergic asthma (with or without rhinitis) | ||
Disease duration (years) | ||
n | 471 | 64.0% |
Mean (±SD) | 3.82 ± 2.91 | |
Severity (GINA 2004)** | ||
Intermittent | 213 | 45.4% |
Mild persistent | 163 | 34.8% |
Moderate persistent | 84 | 17.9% |
Severe persistent | 9 | 1.9% |
Symptoms | ||
Rhinitis (with or without asthma) | ||
Rhinorrhoea | 625 | 89.4% |
Sneezing | 576 | 82.5% |
Nasal obstruction | 575 | 82.3% |
Nasal pruritus | 428 | 61.7% |
Anosmia | 13 | 1.9% |
Asthma (with or without rhinitis) | ||
Cough | 322 | 68.7% |
Wheezing | 245 | 52.1% |
Difficult breathing | 157 | 33.6% |
Chest tightness | 103 | 22.1% |
Rhinitis and/or asthma | ||
Ocular pruritus | 188 | 25.7% |
Teary eyes | 131 | 17.9% |
Other | 84 | 11.7% |